Revolution Medicines, Inc. RVMD 深 沪
等待开盘 02-07 09:30:00 美东时间
97.755
+1.605
+1.67%
华盛通- 最 高124.49
- 今 开97.50
- 成交量 49.95万股
- 最 低 76.28
- 昨 收 96.15
- 总市值 725.78万
- 52周最高 124.49
- 市盈率 静 --
- 换手率 672.79%
- 52周最低 0.00
- 委 比 98.77%
- 总股本 7.42万
- 历史最高 124.49
- 量 比 1.20
- 振 幅 50.14%
- 历史最低 0.00
- 每 手 1
- 风险率 21.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Revolution Medicines Doses First Participant In Clinical Study Of RMC-5127
Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the first patient was dosed in its first-in-human clinical trial
01-29 21:02
Natural Gas Rallies 30%, Silver Jumps 13% To $116: What's Moving Markets Monday?
Natural gas jumps over 30% on winter storm disruptions, silver posts its biggest daily surge since 2008, and stocks grind higher.
01-27 02:26
Gold Rises Over 2%; US Durable Goods Orders Jump In November
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gai...
01-27 01:15
Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday?
Erasca stock fell Monday despite no company news, after reports said Merck ended acquisition talks with cancer drugmaker Revolution Medicines over valuation differences.
01-26 20:52
Revolution Medicines Stock Sinks After Merck Deal Talks Collapse
Merck (NYSE: MRK) reportedly ends discussions to acquire Revolution Medicines (NASDAQ: RVMD) after valuation disagreement.
01-26 19:01
AbbVie Stock Drops After Guidance Update, Wolfe Downgrade And Deal Denial
AbbVie slides after the company cut guidance, Wolfe Research downgraded the stock and the company pushed back on acquisition reports
01-09 02:41
Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of AZZ Inc (NYSE:AZZ) rose in pre-market trading after the company repor...
01-08 17:25
阿斯利康入局，Pan-KRAS抑制剂技术路线之争开始逆转
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ （来源：智通财经） 智通财经APP获悉，在过去几年，围绕Pan-KRAS抑制剂技...
2025-12-22 08:58
2025年，MNC又花了超100亿美元在这个赛道扫货
原标题：2025年，MNC又花了超100亿美元在这个赛道扫货 来源：动脉网 过去，开发小分子药物的关键是找到蛋白质靶点。但是，人体内约有1.9万种蛋白质，绝大...
2025-12-09 08:10
